175 related articles for article (PubMed ID: 9056738)
21. Utility of liquid-based cytology in endometrial pathology: diagnosis of endometrial carcinoma.
Norimatsu Y; Kouda H; Kobayashi TK; Shimizu K; Yanoh K; Tsukayama C; Miyake Y; Ohno E
Cytopathology; 2009 Dec; 20(6):395-402. PubMed ID: 19863617
[TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma.
Isaka K; Nishi H; Nakai H; Nakada T; Feng Li Y; Ebihara Y; Takayama M
Cancer; 2003 Jan; 97(1):79-89. PubMed ID: 12491508
[TBL] [Abstract][Full Text] [Related]
23. Anti-CD9 monoclonal antibody-stimulated invasion of endometrial cancer cell lines in vitro: possible inhibitory effect of CD9 in endometrial cancer invasion.
Park KR; Inoue T; Ueda M; Hirano T; Higuchi T; Konishi I; Fujiwara H; Fujii S
Mol Hum Reprod; 2000 Aug; 6(8):719-25. PubMed ID: 10908282
[TBL] [Abstract][Full Text] [Related]
24. [Flow cytometric analysis of cell surface antigens on leukemia cells by monoclonal antibodies and its application].
Takamoto S; Ueda R; Ota K; Takahashi T
Gan To Kagaku Ryoho; 1982 Jul; 9(7):1191-203. PubMed ID: 7184449
[TBL] [Abstract][Full Text] [Related]
25. Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables.
Ozuysal S; Oztürk H; Bilgin T; Filiz G
Arch Gynecol Obstet; 2005 Feb; 271(2):123-6. PubMed ID: 14740230
[TBL] [Abstract][Full Text] [Related]
26. [Expression of receptor-binding cancer antigen expressed on SiSo cells in endometrial carcinoma and the correlation thereof with the expression of estrogen receptor subtypes].
Zhou XH; Xu ST; Song WY; Teng XD
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1900-3. PubMed ID: 17923013
[TBL] [Abstract][Full Text] [Related]
27. [Flow-cytometric study of aneuploidy and proliferative activity of endometrial cancer cells as indicators of tumor aggressiveness].
Bychkova NV; Meshkova IE; Pozharisskiĭ KM
Vopr Onkol; 1996; 42(2):57-62. PubMed ID: 8815635
[TBL] [Abstract][Full Text] [Related]
28. Liquid-based endometrial cytology: cyto-histological correlation in a population of 917 women.
Buccoliero AM; Gheri CF; Castiglione F; Garbini F; Barbetti A; Fambrini M; Bargelli G; Pappalardo S; Taddei A; Boddi V; Scarselli GF; Marchionni M; Taddei GL
Cytopathology; 2007 Aug; 18(4):241-9. PubMed ID: 17559564
[TBL] [Abstract][Full Text] [Related]
29. Analysis by fluorescence microscopy and flow cytometry of monoclonal antibodies produced against cell surface antigens.
Bolaños B; Bodón Q; Jiménez T; García-Mayol D; Lavergne JA; Díaz AM
P R Health Sci J; 1988 Apr; 7(1):35-8. PubMed ID: 3375422
[TBL] [Abstract][Full Text] [Related]
30. Differential diagnosis of endometrial hyperplasia and carcinoma by computerized image cytometry of cell proliferation, apoptosis and Bcl-2 expression.
Mora LB; Diaz JI; Cantor AB; Nicosia SV
Ann Clin Lab Sci; 1999; 29(4):308-15. PubMed ID: 10528831
[TBL] [Abstract][Full Text] [Related]
31. Expression and prognostic significance of urokinase and plasminogen activator inhibitor type-1 in endometrial hyperplasia and cancer.
Taponeco F; Curcio C; Giuntini A; Nardini V; Fornaciari G; Artini PG; D'Ambrogio G; Genazzani AR
J Exp Clin Cancer Res; 2001 Jun; 20(2):239-46. PubMed ID: 11484981
[TBL] [Abstract][Full Text] [Related]
32. Concomitant endometrial hyperplasia in patients with endometrial carcinoma.
Gücer F; Reich O; Tamussino K; Bader AA; Pieber D; Schöll W; Haas J; Petru E
Gynecol Oncol; 1998 Apr; 69(1):64-8. PubMed ID: 9571000
[TBL] [Abstract][Full Text] [Related]
33. Significance of benign endometrial cells in Pap smears from postmenopausal women.
Wu HH; Schuetz MJ; Cramer H
J Reprod Med; 2001 Sep; 46(9):795-8. PubMed ID: 11584479
[TBL] [Abstract][Full Text] [Related]
34. Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer.
Woo MM; Alkushi A; Verhage HG; Magliocco AM; Leung PC; Gilks CB; Auersperg N
Clin Cancer Res; 2004 Dec; 10(23):7958-64. PubMed ID: 15585630
[TBL] [Abstract][Full Text] [Related]
35. Detection of PTEN immunoreactivity in endometrial hyperplasia and adenocarcinoma.
Tantbirojn P; Triratanachat S; Trivijitsilp P; Niruthisard S
J Med Assoc Thai; 2008 Aug; 91(8):1161-5. PubMed ID: 18788685
[TBL] [Abstract][Full Text] [Related]
36. Expression of cyclin D1 in endometrial hyperplasia and endometrial carcinoma.
Choudhury M; Bansal S
Indian J Pathol Microbiol; 2007 Oct; 50(4):708-10. PubMed ID: 18306533
[TBL] [Abstract][Full Text] [Related]
37. Progesterone treatment decreases sulfate carbohydrate antigen on endometrial carcinoma cells and inhibits the cell binding to laminin.
Kawakita M; Tsuji Y; Nakata Y; Ogasawara T; Takemura T; Isojima S; Koyama K
Gynecol Oncol; 1995 Jun; 57(3):313-20. PubMed ID: 7539773
[TBL] [Abstract][Full Text] [Related]
38. Production of activin A in hyperplasia and adenocarcinoma of the human endometrium.
Otani T; Minami S; Yamoto M; Umesaki N
Gynecol Oncol; 2001 Oct; 83(1):31-8. PubMed ID: 11585411
[TBL] [Abstract][Full Text] [Related]
39. Flow cytometry as a prognostic method for the identification of adenomatous hyperplasia at risk of developing endometrial carcinoma.
Lindahl B; Willén R
Anticancer Res; 1998; 18(6B):4611-2. PubMed ID: 9891527
[TBL] [Abstract][Full Text] [Related]
40. Expression pattern of osteopontin in endometrial carcinoma: correlation with expression of the adhesion molecule CEACAM1.
Briese J; Schulte HM; Bamberger CM; Löning T; Bamberger AM
Int J Gynecol Pathol; 2006 Apr; 25(2):161-9. PubMed ID: 16633066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
